AMPICILLIN SODIUM - Generic Drug Details

What are the generic sources for ampicillin sodium and what is the scope of patent protection?

Ampicillin sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Consolidated Pharm, Eugia Pharma Speclts, Hikma, Hospira, Hq Speclt Pharma, Intl Medication, Istituto Bio Ita Spa, Lilly, Sagent Pharms Inc, Sandoz, Steriscience Speclts, Watson Labs Inc, Wyeth Ayerst, Bristol, Glaxosmithkline, Acs Dobfar, Astral, Hospira Inc, Medimetriks Pharms, and Pfizer, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for ampicillin sodium. Sixteen suppliers are listed for this compound.

Summary for AMPICILLIN SODIUM

US Patents:	0
Tradenames:	7
Applicants:	23
NDAs:	56
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	69
Clinical Trials:	11
Patent Applications:	3,030
What excipients (inactive ingredients) are in AMPICILLIN SODIUM?	AMPICILLIN SODIUM excipients list
DailyMed Link:	AMPICILLIN SODIUM at DailyMed

Recent Clinical Trials for AMPICILLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
M.D. Anderson Cancer Center	Phase 2
Alphacait, LLC	Phase 2
Haining Health-Coming Biotech Co., Ltd.	Phase 2

See all AMPICILLIN SODIUM clinical trials

Pharmacology for AMPICILLIN SODIUM

Drug Class

Penicillin-class Antibacterial

Medical Subject Heading (MeSH) Categories for AMPICILLIN SODIUM

Anti-Bacterial Agents

Anatomical Therapeutic Chemical (ATC) Classes for AMPICILLIN SODIUM

J01CA	Penicillins with extended spectrum
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

S01AA	Antibiotics
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for AMPICILLIN SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	OMNIPEN-N	ampicillin sodium	INJECTABLE;INJECTION	062718-001	Dec 16, 1986		DISCN	No	No
Wyeth Ayerst	OMNIPEN-N	ampicillin sodium	INJECTABLE;INJECTION	062718-003	Dec 16, 1986		DISCN	No	No
Watson Labs Inc	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062816-002	Oct 24, 1988		DISCN	No	No
Glaxosmithkline	TOTACILLIN-N	ampicillin sodium	INJECTABLE;INJECTION	060677-001	Approved Prior to Jan 1, 1982		DISCN	No	No